EDGAR Filing Documents for 0001654954-24-008176

Form DEF 14A - Other definitive proxy statements:

SEC Accession No. 0001654954-24-008176

Filing Date

2024-06-25

Accepted

2024-06-25 16:06:30

Documents

Period of Report

2024-08-06

Document Format Files

Seq	Description	Document	Type	Size
1	DEF 14A	ndra_def14a.htm	DEF 14A	552531
2		ndra_pre14aimg10.jpg	GRAPHIC	3417
3		ndra_pre14aimg11.jpg	GRAPHIC	7302
4		ndra_pre14aimg12.jpg	GRAPHIC	33932
5		ndra_pre14aimg15.jpg	GRAPHIC	162970
6		ndra_pre14aimg16.jpg	GRAPHIC	135550
7		ndra_pre14aimg7.jpg	GRAPHIC	6936
8		ndra_pre14aimg8.jpg	GRAPHIC	1997
9		ndra_pre14aimg9.jpg	GRAPHIC	7299
	Complete submission text file	0001654954-24-008176.txt		1049659

Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105

Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468

ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37969 | Film No.: 241068953
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)